116 related articles for article (PubMed ID: 18413263)
1. Characterization of Kras-mediated pancreatic tumorigenesis in zebrafish.
Davison JM; Woo Park S; Rhee JM; Leach SD
Methods Enzymol; 2008; 438():391-417. PubMed ID: 18413263
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.
Park SW; Davison JM; Rhee J; Hruban RH; Maitra A; Leach SD
Gastroenterology; 2008 Jun; 134(7):2080-90. PubMed ID: 18549880
[TBL] [Abstract][Full Text] [Related]
3. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
4. A case of mistaken identity? Nonductal origins of pancreatic "ductal" cancers.
Murtaugh LC; Leach SD
Cancer Cell; 2007 Mar; 11(3):211-3. PubMed ID: 17349578
[TBL] [Abstract][Full Text] [Related]
5. Physiological analysis of oncogenic K-ras.
Pérez-Mancera PA; Tuveson DA
Methods Enzymol; 2006; 407():676-90. PubMed ID: 16757361
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer.
Schiavone M; Rampazzo E; Casari A; Battilana G; Persano L; Moro E; Liu S; Leach SD; Tiso N; Argenton F
Dis Model Mech; 2014 Jul; 7(7):883-94. PubMed ID: 24878567
[TBL] [Abstract][Full Text] [Related]
7. Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system.
Liu S; Leach SD
Methods Cell Biol; 2011; 105():367-81. PubMed ID: 21951538
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
10. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.
Park JT; Johnson N; Liu S; Levesque M; Wang YJ; Ho H; Huso D; Maitra A; Parsons MJ; Prescott JD; Leach SD
Oncogene; 2015 May; 34(21):2801-6. PubMed ID: 25065594
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor rpl36 restrains KRAS(G12V)-induced pancreatic cancer.
Provost E; Bailey JM; Aldrugh S; Liu S; Iacobuzio-Donahue C; Leach SD
Zebrafish; 2014 Dec; 11(6):551-9. PubMed ID: 25380065
[TBL] [Abstract][Full Text] [Related]
12. Fate mapping of ptf1a-expressing cells during pancreatic organogenesis and regeneration in zebrafish.
Wang YJ; Park JT; Parsons MJ; Leach SD
Dev Dyn; 2015 Jun; 244(6):724-35. PubMed ID: 25773748
[TBL] [Abstract][Full Text] [Related]
13. Translating discovery in zebrafish pancreatic development to human pancreatic cancer: biomarkers, targets, pathogenesis, and therapeutics.
Yee NS; Kazi AA; Yee RK
Zebrafish; 2013 Jun; 10(2):132-46. PubMed ID: 23682805
[TBL] [Abstract][Full Text] [Related]
14. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
[TBL] [Abstract][Full Text] [Related]
15. Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers.
Arena S; Isella C; Martini M; de Marco A; Medico E; Bardelli A
Cancer Res; 2007 Sep; 67(18):8468-76. PubMed ID: 17875685
[TBL] [Abstract][Full Text] [Related]
16. Transgenic zebrafish expressing fluorescent proteins in central nervous system neurons.
Higashijima S
Dev Growth Differ; 2008 Aug; 50(6):407-13. PubMed ID: 18445066
[TBL] [Abstract][Full Text] [Related]
17. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Parinov S; Gong Z
Dis Model Mech; 2012 Jan; 5(1):63-72. PubMed ID: 21903676
[TBL] [Abstract][Full Text] [Related]
18. Heme regulates exocrine peptidase precursor genes in zebrafish.
Wang H; Zhou Q; Kesinger JW; Norris C; Valdez C
Exp Biol Med (Maywood); 2007 Oct; 232(9):1170-80. PubMed ID: 17895525
[TBL] [Abstract][Full Text] [Related]
19. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
Hruban RH; Adsay NV; Albores-Saavedra J; Anver MR; Biankin AV; Boivin GP; Furth EE; Furukawa T; Klein A; Klimstra DS; Kloppel G; Lauwers GY; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Pérez-Gallego L; Redston M; Tuveson DA
Cancer Res; 2006 Jan; 66(1):95-106. PubMed ID: 16397221
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
